BackCorcept Therapeutics Overview
Corcept Therapeutics Inc

Corcept Therapeutics Target Price

Analysts' 12-month price predictions for CORT.

Get informed when a big investor buys or sells

+ Follow

Share Price

$90.47

Average Target Price

$93.002.8% upside

5 analysts in the last 4 months

High: $135 | Low: $72

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-02H.C. WainwrightSwayampakula Ramakanth$955% upsideOpen
2026-05-28UBS$13549.2% upsideOpen
2026-05-13UBS$7220.4% downsideOpen
2026-05-04H.C. Wainwright$7517.1% downsideOpen
2026-05-01Piper Sandler$882.7% downsideOpen
2026-02-20H.C. Wainwright$6725.9% downsideOpen
2026-01-23Canaccord Genuity$10010.5% upsideOpen
2026-01-22H.C. WainwrightSwayampakula Ramakanth$10516.1% upsideOpen
2026-01-02H.C. WainwrightSwayampakula Ramakanth$900.5% downsideOpen
2026-01-02Canaccord GenuityEdward Nash$999.4% upsideOpen
2025-12-31Truist Financial$5044.7% downsideOpen
2025-12-31Wolfe Research$3066.8% downsideOpen
2025-12-16UBSAshwani Verma$955% upsideOpen
2025-09-10Canaccord Genuity$14054.7% upsideOpen
2025-05-06Truist FinancialJoon Lee$13549.2% upsideOpen
2025-05-06H.C. WainwrightSwayampakula Ramakanth$14560.3% upsideOpen
2024-10-18H.C. WainwrightSwayampakula Ramakanth$8011.6% downsideOpen
2024-09-30Truist FinancialJoon Lee$7616% downsideOpen
2024-08-15Canaccord GenuityEdward Nash$7813.8% downsideOpen
2024-07-30Piper SandlerDavid Amsellem$3858% downsideOpen
2024-07-30H.C. WainwrightSwayampakula Ramakanth$4550.3% downsideOpen
2024-06-12Canaccord GenuityEdward Nash$3858% downsideOpen
2024-06-10Piper SandlerDavid Amsellem$3561.3% downsideOpen
2024-06-04Truist FinancialJoon Lee$6528.2% downsideOpen
2024-05-02H.C. WainwrightSwayampakula Ramakanth$4055.8% downsideOpen
2022-12-09H.C. Wainwright$3066.8% downsideOpen
2022-08-04H.C. Wainwright$3363.5% downsideOpen